B · Normal
[Mengke Pharmaceutical: Shareholders Best Idea and JSR plan to reduce their holdings by no more than 6% of the shares] On September 22, Mengke Pharmaceutical (688373.SH) announced that the company’s shareholder BestIdea planned to reduce its holdings by no more than 19.6869 million shares, accounting for 3% of the total share capital; shareholders JSR and GPTMT, as concerted actors, planned to reduce their holdings by no more than 19.6682 million shares, accounting for 3% of the total share capital.
Comments